The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Primary immune thrombocytopenia is an autoimmune disorder characterised by decreased platelet counts and increased bleeding risk. Corticosteroids have been the standard initial treatment of primary immune thrombocytopenia for more than 30 years. The aim of this randomized controlled trial is to compare the efficacy and safety of high-dose dexamethasone in treating new-diagnosed primary immune thrombocytopenia (ITP) in di-cycle and tri-cycle.
Epistemonikos ID: b0f0fa099c202dc23e3522fa8efb0025c8acbb66
First added on: Apr 08, 2025